Medicus Pharma Income Statement (2023-2025) | MDCX

Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter) 0.04M0.03M0.32M1.28M1.37M2.01M1.44M1.68M3.59M
Selling, General & Administrative (Quarter) 0.19M3.81M1.39M2.28M1.77M2.22M3.12M4.58M5.005.20M
Other Operating Expenses (Quarter) 0.56M-1.68M-1.00M
Operating Expenses (Quarter) 0.23M3.84M1.71M3.55M2.33M3.59M5.13M6.02M15.007.79M
Operating Income (Quarter) -0.23M-3.84M-1.71M-3.55M-2.33M-3.59M-5.13M-6.02M-15.00-7.79M
EBIT (Quarter) -0.23M-3.84M-1.71M-3.55M-2.33M-3.59M-5.13M-6.02M-15.00-7.79M
Non-operating items
Interest & Investment Income (Quarter) 0.02M
Other Non Operating Income (Quarter) -0.08M0.06M0.02M-0.16M-0.03M
Non Operating Income (Quarter) 0.19M-1.09M-0.08M0.06M0.05M0.02M-0.16M-0.55M-0.39M
Net income details
EBT (Quarter) -0.23M-3.84M-1.71M-3.55M-2.33M-3.59M-5.10M-6.02M-15.00-7.79M
Profit After Tax (Quarter) -2.96M-1.38M-1.71M-3.63M-2.28M-3.54M-5.10M-6.18M-15.98M-15.07M
Income from Non-Controlling Interests (Quarter) 75.00-69.00
Income from Continuing Operations (Quarter) -0.23M-3.84M-1.71M-3.55M-2.33M-3.59M-5.10M-6.02M-15.00-7.79M
Consolidated Net Income (Quarter) -0.23M-3.84M-1.71M-3.55M-2.33M-3.59M-5.10M-6.02M-15.00-7.79M
Income towards Parent Company (Quarter) -0.23M-3.84M-1.71M-3.55M-2.33M-3.59M-5.10M-6.02M-15.00-7.79M
Net Income towards Common Stockholders (Quarter) -0.23M-3.84M-1.71M-3.55M-2.28M-3.54M-5.10M-6.02M-15.00-15.07M
Additional items
EPS (Basic) (Quarter) -112.31-0.21-0.44-0.24-0.32-0.42-0.43-1.12-0.83
EPS (Weighted Average and Diluted) (Quarter) -1.11-0.21-0.44-0.24-0.32-0.42-0.43-1.12-0.83
Shares Outstanding (Weighted Average) (Quarter) 0.00M8.08M8.17M980.009.62M12.24M14.28M5.94M17.28M
Shares Outstanding (Diluted Average) (Quarter) 3.48M8.08M8.12M9.62M12.24M14.28M18.63M17.28M
EBITDA (Quarter) -0.23M-3.84M-1.71M-3.55M-2.28M-3.54M-5.13M-6.02M-2.00-15.09M
Shares Outstanding (Quarter) 8.08M8.08M11.82M13.42M15.94M20.97M25.18M